Size and dose dependent effects of silver nanoparticle exposure on intestinal permeability in an in vitro model of the human gut epithelium

[1]  G. Chambers,et al.  Silver nanoparticles induce pro‐inflammatory gene expression and inflammasome activation in human monocytes , 2016, Journal of applied toxicology : JAT.

[2]  David M. Brown,et al.  The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line. , 2016, Toxicology letters.

[3]  K. Gokulan,et al.  Dose and Size-Dependent Antiviral Effects of Silver Nanoparticles on Feline Calicivirus, a Human Norovirus Surrogate. , 2016, Foodborne pathogens and disease.

[4]  G. Olson,et al.  Differential Effects of Silver Nanoparticles and Silver Ions on Tissue Accumulation, Distribution, and Toxicity in the Sprague Dawley Rat Following Daily Oral Gavage Administration for 13 Weeks. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  L. Hoffmann,et al.  Effects of silver nanoparticles and ions on a co-culture model for the gastrointestinal epithelium , 2015, Particle and Fibre Toxicology.

[6]  K. Gokulan,et al.  Human Intestinal Microbial Biofilm and its Correlation with Intestinal Mucin Secretion , 2015 .

[7]  Denis C. Bauer,et al.  Early life events influence whole-of-life metabolic health via gut microflora and gut permeability , 2015, Critical reviews in microbiology.

[8]  C. Cerniglia,et al.  Effects of subchronic exposure of silver nanoparticles on intestinal microbiota and gut-associated immune responses in the ileum of Sprague-Dawley rats , 2015, Nanotoxicology.

[9]  T. Begley,et al.  Characterisation and potential migration of silver nanoparticles from commercially available polymeric food contact materials , 2015, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[10]  J. Mast,et al.  TEM and SP-ICP-MS analysis of the release of silver nanoparticles from decoration of pastry. , 2015, Journal of agricultural and food chemistry.

[11]  S. Gaillet,et al.  Silver nanoparticles: their potential toxic effects after oral exposure and underlying mechanisms--a review. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  H. Ghorbani.  Biological coating of paper using silver nanoparticles. , 2014, IET nanobiotechnology.

[13]  Horst-Günter Rubahn,et al.  Exposure to silver nanoparticles induces size- and dose-dependent oxidative stress and cytotoxicity in human colon carcinoma cells. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  T. Tetley,et al.  Inhaled silver nanoparticles induce pulmonary oxidative injury and inflammation: Differential effects between rat strains , 2014 .

[15]  Alfonso Lampen,et al.  Analytically monitored digestion of silver nanoparticles and their toxicity on human intestinal cells , 2014, Nanotoxicology.

[16]  J. Patel,et al.  Toxicity of Nanomaterials on the Gastrointestinal Tract , 2014 .

[17]  Sahil Gupta,et al.  Cell‐death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques , 2014, Journal of microscopy.

[18]  Carolina Alves Dos Santos,et al.  Silver nanoparticles: therapeutical uses, toxicity, and safety issues. , 2014, Journal of pharmaceutical sciences.

[19]  Qingtao Li,et al.  Nanosilver particles in medical applications: synthesis, performance, and toxicity , 2014, International journal of nanomedicine.

[20]  Robert I. MacCuspie,et al.  Identification and Avoidance of Potential Artifacts and Misinterpretations in Nanomaterial Ecotoxicity Measurements , 2014, Environmental science & technology.

[21]  N. Hadrup,et al.  Oral toxicity of silver ions, silver nanoparticles and colloidal silver--a review. , 2014, Regulatory toxicology and pharmacology : RTP.

[22]  F. Barreau,et al.  Intestinal barrier dysfunction triggered by invasive bacteria. , 2014, Current opinion in microbiology.

[23]  Haifang Wang,et al.  Progress in the characterization and safety evaluation of engineered inorganic nanomaterials in food. , 2013, Nanomedicine.

[24]  J. Maillard,et al.  Silver as an antimicrobial: facts and gaps in knowledge , 2013, Critical reviews in microbiology.

[25]  J. Turner,et al.  Intestinal permeability defects: is it time to treat? , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  M. Vecchi,et al.  Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned from Animal Models and Human Genetics , 2013, Front. Immunol..

[27]  A. Hensel,et al.  State of the art in human risk assessment of silver compounds in consumer products: a conference report on silver and nanosilver held at the BfR in 2012 , 2013, Archives of Toxicology.

[28]  K. Schwab,et al.  Toxicity of commercially available engineered nanoparticles to Caco-2 and SW480 human intestinal epithelial cells , 2013, Cell Biology and Toxicology.

[29]  H. Garner,et al.  Systems Biology Analysis of Gene Expression during In Vivo Mycobacterium avium paratuberculosis Enteric Colonization Reveals Role for Immune Tolerance , 2012, PloS one.

[30]  H. Bouwmeester,et al.  Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. , 2012, ACS nano.

[31]  S. Lechuga,et al.  ZO‐2, a tight junction scaffold protein involved in the regulation of cell proliferation and apoptosis , 2012, Annals of the New York Academy of Sciences.

[32]  A. Lampen,et al.  Cytotoxicity of peptide-coated silver nanoparticles on the human intestinal cell line Caco-2 , 2012, Archives of Toxicology.

[33]  W. D. de Jong,et al.  The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. , 2011, Biomaterials.

[34]  H. Arlinghaus,et al.  Toxicity of silver nanoparticles in human macrophages: uptake, intracellular distribution and cellular responses , 2011 .

[35]  F. Sotgia,et al.  Caveolin-2-deficient mice show increased sensitivity to endotoxemia , 2011, Cell cycle.

[36]  Hans Bouwmeester,et al.  Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. , 2011, ACS nano.

[37]  Bernd Nowack,et al.  120 years of nanosilver history: implications for policy makers. , 2011, Environmental science & technology.

[38]  S. Khare,et al.  Early Phase Morphological Lesions and Transcriptional Responses of Bovine Ileum Infected with Mycobacterium avium subsp. paratuberculosis , 2009, Veterinary pathology.

[39]  N. Bradbury,et al.  Rab11b regulates the apical recycling of the cystic fibrosis transmembrane conductance regulator in polarized intestinal epithelial cells. , 2009, Molecular biology of the cell.

[40]  J. Hanes,et al.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. , 2009, Advanced drug delivery reviews.

[41]  Paul Westerhoff,et al.  Nanoparticle silver released into water from commercially available sock fabrics. , 2008, Environmental science & technology.

[42]  A. Rizzo,et al.  IL‐23‐mediated regulation of IL‐17 production in Helicobacter pylori‐infected gastric mucosa , 2008, European journal of immunology.

[43]  K. Woo,et al.  So What If You Are Blue? Oral Colloidal Silver and Argyria Are Out: Safe Dressings Are In , 2007, Advances in skin & wound care.

[44]  Michael V Sefton,et al.  Endotoxin: the uninvited guest. , 2005, Biomaterials.

[45]  D. Norris,et al.  BMC Biotechnology BioMed Central Methodology article A simple technique for quantifying apoptosis in 96-well plates , 2005 .

[46]  A. Hopkins,et al.  Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms 1 , 2003, The Journal of Immunology.

[47]  S. Silver,et al.  Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. , 2003, FEMS microbiology reviews.

[48]  M. Ahdieh,et al.  Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. , 1999, The American journal of physiology.

[49]  M. Ahdieh,et al.  Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[50]  S. Planchon,et al.  IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. , 1993, Journal of immunology.

[51]  Sangeeta Khare,et al.  Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. , 2015, ALTEX.

[52]  P. Aronson,et al.  Cholinergic signaling inhibits oxalate transport by human intestinal T84 cells. , 2012, American journal of physiology. Cell physiology.

[53]  C. Abbott,et al.  Studying permeability in a commonly used epithelial cell line: T84 intestinal epithelial cells. , 2011, Methods in molecular biology.